SALA, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.264
EU - Europa 1.404
AS - Asia 961
SA - Sud America 45
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 13
OC - Oceania 10
Totale 4.712
Nazione #
US - Stati Uniti d'America 2.231
CN - Cina 607
IT - Italia 351
SE - Svezia 185
IE - Irlanda 175
DE - Germania 142
SG - Singapore 100
FR - Francia 98
AT - Austria 95
FI - Finlandia 88
UA - Ucraina 76
KR - Corea 61
JP - Giappone 58
DK - Danimarca 48
GB - Regno Unito 45
VN - Vietnam 40
BR - Brasile 39
PL - Polonia 38
BE - Belgio 30
CA - Canada 27
IN - India 27
TW - Taiwan 16
EU - Europa 15
HK - Hong Kong 15
IR - Iran 13
ES - Italia 10
SN - Senegal 10
AU - Australia 8
TH - Thailandia 8
RU - Federazione Russa 6
MX - Messico 5
NL - Olanda 5
MY - Malesia 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
RO - Romania 2
BG - Bulgaria 1
BW - Botswana 1
BZ - Belize 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
MO - Macao, regione amministrativa speciale della Cina 1
NA - Namibia 1
NO - Norvegia 1
SA - Arabia Saudita 1
Totale 4.712
Città #
Chandler 396
Beijing 206
Ann Arbor 186
Dublin 174
Torino 163
Ashburn 127
Fairfield 115
Houston 99
Vienna 94
Nyköping 85
Villeurbanne 74
Singapore 71
Jacksonville 64
Wilmington 64
Medford 57
Dearborn 56
Shenyang 53
Guangzhou 50
Princeton 50
Cambridge 44
Pisa 44
Woodbridge 43
Seattle 36
Fremont 32
Warsaw 30
Dong Ket 28
Boston 23
Fortaleza 21
Shanghai 21
Turin 20
Nanjing 19
Boardman 17
Redwood City 17
Brussels 15
Toronto 15
Hangzhou 12
Santa Clara 12
Asti 11
New York 11
Tokyo 10
Chengdu 9
Hefei 9
Milan 9
Munich 8
Norwalk 8
Kunming 7
London 6
Maasmechelen 6
Madrid 6
Phoenix 6
San Mateo 6
Seoul 6
Tehran 6
Washington 6
Wuhan 6
Xi'an 6
Hong Kong 5
Hsinchu 5
Leeds 5
Los Angeles 5
Shenzhen 5
Xian 5
Zhengzhou 5
Auburn 4
Central District 4
Foshan 4
Goiânia 4
Guiyang 4
Harbin 4
Hasselt 4
Hebei 4
Helsinki 4
Nürnberg 4
Pune 4
Qingdao 4
San Diego 4
Silver Spring 4
Trieste 4
Bangkok 3
Berlin 3
Bologna 3
Bydgoszcz 3
Changsha 3
Chongqing 3
Edmonton 3
Fuzhou 3
Las Vegas 3
Louvain-la-Neuve 3
Nanchang 3
Nuremberg 3
Paris 3
Rome 3
San Jose 3
Sydney 3
Taipei 3
Tianjin 3
Verona 3
Wenzhou 3
Ardea 2
Belo Horizonte 2
Totale 2.934
Nome #
Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth 565
MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine 283
Transgenic models of cardiac cachexia and cardiac effects of muscular atrophy 219
Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes 194
Sustained Met signalling in the heart leads to cardiac compensated hypertrophy and remodelling, which evolves into congestive heart failure 176
Activated Met Signalling in the Developing Mouse Heart Leads to Cardiac Disease 169
A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart 156
PI3K Signaling in Tissue Hyper-Proliferation: From Overgrowth Syndromes to Kidney Cysts 156
Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy 154
Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis 144
Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF) 122
Gene expression profiling of HGF/Met activation in neonatal mouse heart 105
HGF receptor agonists protect cardiomyocytes from CoCl2-induced cell injury 102
Cellular and molecular mechanisms of HGF/Met in the cardiovascular system 101
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib 100
HGF-mediated modulation of Connexin 43 in cardiac cells 93
HGF/Met tyrosine kinase receptor in heart physiology and pathophysiology 93
Mek1 inhibition in vivo mitigates progressive cardiac concentric hypertrophy promoted by activated Met receptor. 90
Cardiac glycosides as new modulators of cholesterol metabolism 88
Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes 88
HGF receptor agonists protect cardiomyocytes from CoCl2-induced cell injury 82
Met activation for cardioprotection against anthracycline cardiotoxicity. 79
Digoxin and ouabain induce the efflux of cholesterol via LXR signalling and the synthesis of ATP in cardiomyocytes. 77
New mouse models to study HGF/Met role in postnatal heart development and heart disease pathogenesis 74
Signaling to cardiac hypertrophy: insights from human and mouse RASopathies 72
Met activation for cardioprotection against anthracyclines cardiotoxicity 71
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 71
Cardiac expression of hepatocyte growth factor increases adultneovascularization 70
HGF/c-Met in postnatal heart development 70
Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation 70
Conditional expression of hepatocyte growth factor in cardiac and skeletal muscle for regeneration studies 66
Gain-of-function mouse models of the hgf/met axis reveal cardiac defects 66
New mouse models to study pathological consequences of chronical activation of HGF/c-MET axis specifically in the heart 65
A mouse model for spatial and temporal expression of HGF in the heart 65
High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly 64
Conditional expression of hepatocyte growth factor in cardiac and skeletal muscle for regeneration studies 61
HGF/Met Axis in Heart Function and Cardioprotection 60
HGF/Met axis has anti-apoptotic and anti-autophagic function in hypoxic cardiac injury 59
Preventing and Treating Anthracycline Cardiotoxicity: New Insights 53
Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectives 51
Signaling pathways underlying anthracycline cardiotoxicity 50
Mice with inducible cardiomyocyte expression of hepatocyte growth factor develop sistoli contractile dysfunction 49
Inhaled Biologicals for the Treatment of Cystic Fibrosis 49
Novel therapy for myocardial infarction: can HGF/Met be beneficial? 47
P2 RAPID IN VITRO HEPATOCYTE GENERATION FROM ADULT PROGENITOR CELLS AND LEUKEMIC CELL LINE THP-1 USING ELECTROMAGNETIC FIELD 39
New avenues in cardio-oncology 38
Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia 33
Roles of phosphatidyl inositol 3 kinase gamma (PI3Kγ) in respiratory diseases 30
Totale 4.879
Categoria #
all - tutte 14.158
article - articoli 0
book - libri 0
conference - conferenze 4.911
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.069


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020524 0 0 21 76 30 103 73 42 41 70 43 25
2020/2021481 40 35 16 24 47 21 61 10 63 52 37 75
2021/2022671 37 26 29 56 40 24 34 36 18 60 202 109
2022/20231.021 97 112 18 89 101 248 54 61 129 41 31 40
2023/2024609 70 94 39 34 43 84 40 55 11 47 40 52
2024/2025208 24 163 21 0 0 0 0 0 0 0 0 0
Totale 4.879